DE69921530D1 - Behandlung einer Virusinfektion bei Schweinen - Google Patents

Behandlung einer Virusinfektion bei Schweinen

Info

Publication number
DE69921530D1
DE69921530D1 DE69921530T DE69921530T DE69921530D1 DE 69921530 D1 DE69921530 D1 DE 69921530D1 DE 69921530 T DE69921530 T DE 69921530T DE 69921530 T DE69921530 T DE 69921530T DE 69921530 D1 DE69921530 D1 DE 69921530D1
Authority
DE
Germany
Prior art keywords
treatment
pigs
virus infection
tilmicosin
swine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69921530T
Other languages
English (en)
Other versions
DE69921530T2 (de
Inventor
Gregory Alan Armbruster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69921530D1 publication Critical patent/DE69921530D1/de
Application granted granted Critical
Publication of DE69921530T2 publication Critical patent/DE69921530T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE69921530T 1998-03-02 1999-03-01 Behandlung einer Virusinfektion bei Schweinen Expired - Lifetime DE69921530T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7646698P 1998-03-02 1998-03-02
US76466P 1998-03-02

Publications (2)

Publication Number Publication Date
DE69921530D1 true DE69921530D1 (de) 2004-12-09
DE69921530T2 DE69921530T2 (de) 2005-10-27

Family

ID=22132217

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69921530T Expired - Lifetime DE69921530T2 (de) 1998-03-02 1999-03-01 Behandlung einer Virusinfektion bei Schweinen

Country Status (16)

Country Link
US (1) US6034070A (de)
EP (1) EP0948967B1 (de)
JP (1) JP4555472B2 (de)
AT (1) ATE281173T1 (de)
AU (1) AU2979899A (de)
CA (1) CA2322327C (de)
CO (1) CO5080775A1 (de)
DE (1) DE69921530T2 (de)
DK (1) DK0948967T3 (de)
ES (1) ES2230802T3 (de)
MY (1) MY124071A (de)
PT (1) PT948967E (de)
SI (1) SI0948967T1 (de)
TW (1) TW565452B (de)
WO (1) WO1999044619A1 (de)
ZA (1) ZA991641B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506885B1 (en) * 2001-09-27 2003-01-14 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
AU2002335077B2 (en) * 2001-10-19 2006-09-07 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
WO2003078411A1 (en) 2002-03-12 2003-09-25 Bristol-Myers Squibb Company C3-cyano epothilone derivatives
US7282487B2 (en) * 2004-10-28 2007-10-16 Idexx Laboratories Method for treating bacterial infections in horses or pigs with tilmicosin
JP5323696B2 (ja) 2006-07-28 2013-10-23 インターベツト・インターナシヨナル・ベー・ベー マクロライド合成方法
CN103288904B (zh) * 2013-06-28 2015-07-15 宁夏泰瑞制药股份有限公司 一种磷酸替米考星晶体的制备方法
CN103483406A (zh) * 2013-09-25 2014-01-01 宁夏泰瑞制药股份有限公司 一种磷酸替米考星的制备方法
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
AU561147B2 (en) * 1982-09-13 1987-04-30 Eli Lilly And Company 20-amino macrolide antibiotics
US5574020A (en) * 1989-09-28 1996-11-12 Eli Lilly And Company Tilmicosin formulation
US5695766A (en) * 1992-10-30 1997-12-09 Iowa State University Research Foundation Highly virulent porcine reproductive and respiratory syndrome viruses which produce lesions in pigs and vaccines that protect pigs against said syndrome
GB2289279B (en) * 1994-05-13 1998-09-16 Iberica Cyanamid Diagnostic kits and vaccines containing recombinant PRRSV proteins
ES2223058T3 (es) * 1995-03-14 2005-02-16 Akzo Nobel N.V. Expresion en la misma celula de polipeptidos del virus del sindrome reproductivo y respiratorio porcino.

Also Published As

Publication number Publication date
EP0948967A2 (de) 1999-10-13
EP0948967A3 (de) 1999-10-20
JP4555472B2 (ja) 2010-09-29
DK0948967T3 (da) 2005-02-14
MY124071A (en) 2006-06-30
AU2979899A (en) 1999-09-20
US6034070A (en) 2000-03-07
PT948967E (pt) 2005-02-28
WO1999044619A1 (en) 1999-09-10
EP0948967B1 (de) 2004-11-03
CA2322327C (en) 2009-12-22
ATE281173T1 (de) 2004-11-15
ES2230802T3 (es) 2005-05-01
CO5080775A1 (es) 2001-09-25
CA2322327A1 (en) 1999-09-10
SI0948967T1 (en) 2005-06-30
TW565452B (en) 2003-12-11
DE69921530T2 (de) 2005-10-27
ZA991641B (en) 2000-09-01
JP2002505294A (ja) 2002-02-19

Similar Documents

Publication Publication Date Title
BR0309581A (pt) Derivados de nucleosìdeo para tratamento de infecção por vìrus de hepatite c
AP1782A (en) Use of compounds ?-D or ?-L nucleoside for treating hepatitis C virus.
ATE295355T1 (de) Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen
CO5210911A1 (es) Trifluorbutenos nematicidas
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE69823344D1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
EA200000840A1 (ru) Антивирусные производные пиримидина
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
BR9909668A (pt) Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções
PT768086E (pt) Tratamento de tinido utilizando agentes neuroprotectores
DK1109817T3 (da) Phosphohalogenhydriner, deres fremstilling og anvendelse
DE69921530D1 (de) Behandlung einer Virusinfektion bei Schweinen
KR970704768A (ko) 사람 면역결핍증 바이러스의 증식을 억제하는 화합물 및 방법(Compounds and Methods for Inhibiting Propagation of Human Immunoefficiency Virus)
DK0750616T3 (da) Syreadditionssalte af 2,3,4,5-tetrahydro-1H-3-benzazapinforbindelser
ATE457734T1 (de) Kombinationstherapie zur behandlung von hepatitis b infektionen
ID21874A (id) Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit
EA200100711A1 (ru) Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция
ATE129250T1 (de) Carboxamidderivate.
PT98268A (pt) Processo para a preparacao de indano-pirrolidino-carbamatos
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
PT821955E (pt) Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para o tratamento da doenca bipolar
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
EA200001065A1 (ru) Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций
KR950022792U (ko) 시술용 수지침의 소독기

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN